An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)

NCT01791153 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: Tocilizumab
DRUG: Prednisone
DRUG: Tocilizumab Placebo
DRUG: Prednisone Placebo
DRUG: Corticosteroids
DRUG: Methotrexate

Sponsor

Hoffmann-La Roche